Bolt Biotherapeutics Inc — Quarterly Financial Statistics (NASDAQ:BOLT) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -14.43 M-13.37 M-9.6 M-9.73 M-7.16 M -39.85 M Cash from investing activities 12.23 M14.55 M10.79 M17.88 M1.07 M 44.3 M Cash from financing activities 29 K014 K05 000 19 K Free cash flow -14.43 M-13.37 M-9.6 M-9.73 M-7.16 M -39.85 M

News

Bolt Biotherapeutics, Inc. (BOLT) Reports Q4 Loss, Tops Revenue Estimates

Bolt Biotherapeutics, Inc. (BOLT) Reports Q3 Loss, Beats Revenue Estimates

Bolt Biotherapeutics, Inc. (BOLT) Expected to Beat Earnings Estimates: Should You Buy?

Bolt Biotherapeutics CEO Quinn buys shares worth $686

Nemec, Bolt Biotherapeutics SVP, acquired shares worth $686

Bolt Biotherapeutics stock initiated with Buy rating at H.C. Wainwright

Fidus Investment, Rocket Companies And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Mr. Cooper Gr (NASDAQ:COOP), Bolt Biotherapeutics (NASDAQ:BOLT)

Bolt Biotherapeutics delays clinical data, cuts workforce by half

Bolt Biotherapeutics stock falls after clinical data delay to 2026

Bolt Biotherapeutics stock price target cut to $6 from $20 at Leerink Partners

Bolt earnings missed by $4.15, revenue topped estimates

Bolt Biotherapeutics, Inc. (BOLT) Reports Q2 Loss, Tops Revenue Estimates